The DOI matches its Crossref record; 99 of the 100 references it cites were found in a registry or an index.
Statins, cognition, and dementia-systematic review and methodological commentary
Open accessAbstract
Firm conclusions about whether mid-life or long-term statin use has an impact on cognitive decline and dementia remain elusive. Here, our objective was to systematically review, synthesize and critique the epidemiological literature that examines the relationship between statin use and cognition, so as to assess the current state of knowledge, identify gaps in our understanding, and make recommendations for future research. We summarize the findings of randomized controlled trials (RCTs) and observational studies, grouped according to study design. We discuss the methods for each, and consider likely sources of bias, such as reverse causation and confounding. Although observational studies that considered statin use at or near the time of dementia diagnosis suggest a protective effect of statins, these findings could be attributable to reverse causation. RCTs and well-conducted observational studies of baseline statin use and subsequent cognition over several years of follow-up do not support a causal preventative effect of late-life statin use on cognitive decline or dementia. Given that much of the human research on statins and cognition in the future will be observational, careful study design and analysis will be essential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“statins have not been shown to prevent dementia (6, 7).”
From Oversimplification of Dementia Risk Reduction Messaging Is a Threat to Knowledge Translation in Dementia Prevention Research (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Power failure: why small sample size undermines the reliability of neuroscience
Button, K. S., Ioannidis, J. P. A., Mokrysz, C., Nosek, B. A., Flint, J., Robinson, E. S. J., & Munafò, M. R. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3475 · Cited by 7,641
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
(1992) · Applied Ergonomics · doi:10.1016/0003-6870(92)90318-p · Cited by 5,774
Marginal Structural Models and Causal Inference in Epidemiology
Robins, J. M., Hernán, M. Á., & Brumback, B. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00011 · Cited by 5,581
Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade
Jack, C. R., Knopman, D. S., Jagust, W. J., Shaw, L. M., Aisen, P. S., Weiner, M. W., Petersen, R. C., & Trojanowski, J. Q. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70299-6 · Cited by 4,806
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
A structural approach to selection bias
Hernán, M. A., Hernández-Díaz, S., & Robins, J. M. (2004) · Epidemiology · doi:10.1097/01.ede.0000135174.63482.43 · Cited by 2,844
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Hernán, M. Á., Brumback, B., & Robins, J. M. (2000) · Epidemiology · doi:10.1097/00001648-200009000-00012 · Cited by 1,772
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
The age-dependent relation of blood pressure to cognitive function and dementia
Qiu, C., Winblad, B., & Fratiglioni, L. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70141-1 · Cited by 1,138
Wada, K., Tanaka, K., & Nakashima, K. (2011) · PubMed · Cited by 1,132
Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms
Jain, M. K., & Ridker, P. M. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1901 · Cited by 930
Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model
Refolo, L. M., Pappolla, M. A., Malester, B., LaFrancois, J., Bryant-Thomas, T., Wang, R., Tint, G. S., Sambamurti, K., & Duff, K. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0304 · Cited by 783
Glymour, M. M., Weuve, J., Berkman, L. F., Kawachi, I. I., & Robins, J. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi187 · Cited by 706
Self-citationApplication of New Cholesterol Guidelines to a Population-Based Sample
Pencina, M. J., Navar‐Boggan, A. M., D’Agostino, R. B., Williams, K., Neely, B., Sniderman, A. D., & Peterson, E. D. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315665 · Cited by 612
Statistical Models in Epidemiology, the Environment, and Clinical Trials
Halloran, M. E., & Berry, D. A. (2000) · The IMA volumes in mathematics and its applications · doi:10.1007/978-1-4612-1284-3 · Cited by 559
Hippisley‐Cox, J., & Coupland, C. A. C. (2010) · BMJ · doi:10.1136/bmj.c2197 · Cited by 511
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub3 · Cited by 490
Anstey, K. J., Lipnicki, D. M., & Low, L. (2008) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000310778.20870.ae · Cited by 480
Haag, M. D. M., Hofman, A., Koudstaal, P. J., Stricker, B. H. C., & Breteler, M. M. B. (2009) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.150433 · Cited by 393
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease
Wolozin, B. L., Wang, S. W., Li, N.-C., Lee, A. F., Lee, T. A., & Kazis, L. E. (2007) · BMC Medicine · doi:10.1186/1741-7015-5-20 · Cited by 391
Confounding in Health Research
Greenland, S., & Morgenstern, H. (2001) · Annual Review of Public Health · doi:10.1146/annurev.publhealth.22.1.189 · Cited by 390
Brookhart, M. A., Patrick, A. R., Dormuth, C. R., Avorn, J., Shrank, W. H., Cadarette, S. M., & Solomon, D. H. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm070 · Cited by 386
The Accuracy of Medicare Claims as an Epidemiological Tool: The Case of Dementia Revisited
Taylor, Jr., Østbye, T., Langa, K. M., Weir, D., & Plassman, B. L. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1099 · Cited by 354
Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease? The Cache County Study
Zandi, P. P. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.2.217 · Cited by 317
Statins for the primary prevention of cardiovascular disease
Taylor, F. C., Ward, K. J., Moore, T. H., Burke, M., Smith, G. D., Casas, J. P., & Ebrahim, S. B. J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub4 · Cited by 315
Pravastatin and cognitive function in the elderly. Results of the PROSPER study
Trompet, S., Vliet, P., Craen, A. J. M., Jolles, J., Buckley, B. M., Murphy, M. B., Ford, I., Macfarlane, P. W., Sattar, N., Packard, C. J., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5271-7 · Cited by 291
Effects of lovastatin on cognitive function and psychological well-being
Muldoon, M. F., Barger, S. D., Ryan, C. M., Flory, J. D., Lehoczky, J. P., Matthews, K. A., & Manuck, S. B. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00353-3 · Cited by 290
Statin Use and the Risk of Incident Dementia
Rea, T. D., Breitner, J. C. S., Psaty, B. M., Fitzpatrick, A. L., López, O. L., Newman, A. B., Hazzard, W. R., Zandi, P. P., Burke, G. L., Lyketsos, C. G., et al. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1047 · Cited by 277
Use of statins and incidence of dementia and cognitive impairment without dementia in a cohort study
Cramer, C., Haan, M. N., Galea, S., Langa, K. M., & Kalbfleisch, J. D. (2008) · Neurology · doi:10.1212/01.wnl.0000319647.15752.7b · Cited by 255
Sierra, S., Ramos, M. C., Molina, P., Esteo, C., Vázquez, J. A., & Burgos, J. S. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101179 · Cited by 254
Statin therapy and risk of dementia in the elderly
Li, G., Higdon, R., Kukull, W. A., Peskind, E. R., Moore, K. V. V., Tsuang, D. W., van Belle, G., McCormick, W. C., Bowen, J. D., Teri, L. L., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000142963.90204.58 · Cited by 250
Statins and Cognitive Function: A Systematic Review
Richardson, K., Schoen, M., French, B., Umscheid, C. A., Mitchell, M. D., Arnold, S. E., Heidenreich, P. A., Rader, D. J., & deGoma, E. M. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00007 · Cited by 250
Muldoon, M. F., Ryan, C. M., Sereika, S. M., Flory, J. D., & Manuck, S. B. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.07.041 · Cited by 250
Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease
Li, G., Larson, E. B., Sonnen, J. A., Shofer, J. B., Petrie, E. C., Schantz, A. M., Peskind, E. R., Raskind, M. A., Breitner, J. C. S., & Montine, T. J. (2007) · Neurology · doi:10.1212/01.wnl.0000277657.95487.1c · Cited by 240
APOE genotype, cholesterol level, lipid-lowering treatment, and dementia
Dufouil, C., Richard, F., Fiévet, N., Dartigues, J., Ritchie, K. A., Tzourio, C., Amouyel, P., & Alpérovitch, A. (2005) · Neurology · doi:10.1212/01.wnl.0000160114.42643.31 · Cited by 238
Smeeth, L. L., Douglas, I., Hall, A. J., Hubbard, R., & Evans, S. J. W. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03308.x · Cited by 236
Swiger, K. J., Manalac, R. J., Blumenthal, R. S., Blaha, M. J., & Martin, S. S. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.07.013 · Cited by 233
Survival of people with clinical diagnosis of dementia in primary care: cohort study
Rait, G., Walters, K., Bottomley, C., Petersen, I., Iliffe, S., & Nazareth, I. (2010) · BMJ · doi:10.1136/bmj.c3584 · Cited by 221
Statin‐Associated Adverse Cognitive Effects: Survey Results from 171 Patients
Evans, M. A., & Golomb, B. A. (2009) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.29.7.800 · Cited by 209
Statins, incident Alzheimer disease, change in cognitive function, and neuropathology
Arvanitakis, Z., Schneider, J. A., Wilson, R. S., Bienias, J. L., Kelly, J. F., Evans, D. A., & Bennett, D. A. (2008) · Neurology · doi:10.1212/01.wnl.0000288181.00826.63 · Cited by 203
Naci, H., Brugts, J. J., Fleurence, R., Tsoi, B., Toor, H., & Ades, A. (2013) · European Journal of Preventive Cardiology · doi:10.1177/2047487313480435 · Cited by 202
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub2 · Cited by 193
Lipid metabolism in cognitive decline and dementia
Panza, F., D’Introno, A., Colacicco, A. M., Capurso, C. A., Pichichero, G., Capurso, S. A., Capurso, A., & Solfrizzi, V. (2006) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.11.007 · Cited by 188
Reduction in Levels of 24S-Hydroxycholesterol by Statin Treatment in Patients With Alzheimer Disease
Vega, G. L., Weiner, M., Lipton, A. M., von Bergmann, K., Lütjohann, D., Moore, C. B., & Svetlik, D. A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.4.510 · Cited by 172
Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease
Fox, N. C., Warrington, E. K., & Rossor, M. N. (1999) · The Lancet · doi:10.1016/s0140-6736(99)00496-1 · Cited by 163
Statins and cognitive function in the elderly
Bernick, C. B., Katz, R., Smith, N. L., Rapp, S., Bhadelia, R. A., Carlson, M. C., & Kuller, L. H. (2005) · Neurology · doi:10.1212/01.wnl.0000182897.18229.ec · Cited by 161
Locatelli, S., Lütjohann, D., Schmidt, H., Otto, C., Beisiegel†, U., & von Bergmann, K. (2002) · Archives of Neurology · doi:10.1001/archneur.59.2.213 · Cited by 152
Bettermann, K., Arnold, A. M., Williamson, J. D., Rapp, S. R., Sink, K. M., Toole, J. F., Carlson, M. C., Yaşar, S., DeKosky, S. T., & Burke, G. L. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2010.11.002 · Cited by 135
Wong, W. B., Lin, V. W., Boudreau, D. M., & Devine, E. B. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3381 · Cited by 124
Fassbender, K. C., Stroick, M., Bertsch, T., Ragoschke, A., Kuehl, S., Walter, S., Walter, J., Brechtel-Curth, K., Muehlhauser, F., von Bergmann, K., et al. (2002) · Neurology · doi:10.1212/wnl.59.8.1257 · Cited by 119
Rojas‐Fernandez, C. H., & Cameron, J.-C. F. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q620 · Cited by 116
Statins and serum cholesterol's associations with incident dementia and mild cognitive impairment
Beydoun, M. A., Beason‐Held, L. L., Kitner‐Triolo, M. H., Beydoun, H. A., Ferrucci, L., Resnick, S. M., & Zonderman, A. B. (2010) · Journal of Epidemiology & Community Health · doi:10.1136/jech.2009.100826 · Cited by 115
Age‐Varying Association Between Statin Use and Incident Alzheimer's Disease
Li, G., Shofer, J. B., Rhew, I. C., Kukull, W. A., Peskind, E. R., McCormick, W. C., Bowen, J. D., Schellenberg, G. D., Crane, P. K., Breitner, J. C. S., et al. (2010) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2010.02906.x · Cited by 113
Harrison, R., & Ashton, C. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04268.x · Cited by 113
van den Dungen, P., van Marwijk, H., van der Horst, H. E., van Charante, E. P. M., Vroomen, J. L. M., van de Ven, P. M., & van Hout, H. P. J. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2726 · Cited by 111
Santanello, N. C., Barber, B., Applegate, W. B., Elam, J. T., Curtis, C., Hunninghake, D. B., Gordon, D. J., & For the CRISP Collaborative Study Group (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb00971.x · Cited by 101
Prevention and Treatment of Dementia or Alzheimer’s Disease by Statins: A Meta-Analysis
Zhou, B., Teramukai, S., & Fukushima, M. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099037 · Cited by 99
24S-Hydroxycholesterol: a Marker of Brain Cholesterol Metabolism
Lütjohann, D., & von Bergmann, K. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43053 · Cited by 97
Reduced Risk of Incident AD with Elective Statin Use in a Clinical Trial Cohort
Sparks, D., Kryscio, R., Sabbagh, M., Connor, D., Sparks, L., & Liebsack, C. (2008) · Current Alzheimer Research · doi:10.2174/156720508785132316 · Cited by 92
Carlsson, C. M., Gleason, C. E., Hess, T., Moreland, K. A., Blazel, H. M., Koscik, R. L., Schreiber, N. T. N., Johnson, S. C., Atwood, C., Puglielli, L., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13209 · Cited by 92
Effect of statins on Alzheimer’s disease biomarkers in cerebrospinal fluid
Riekse, R. G., Li, G., Petrie, E. C., Leverenz, J. B., Vavrek, D., Vuletic, S., Albers, J. J., Montine, T. J., Lee, V. M.-Y., Lee, M., et al. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-10408 · Cited by 90
Lipid Lowering Agents, Cognitive Decline, and Dementia: The Three-City Study
Ancelin, M., Carrière, I., Barberger‐Gateau, P., Auriacombe, S., Rouaud, O., Fourlanos, S., Berr, C., Dupuy, A., & Ritchie, K. A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120064 · Cited by 82
Association of statin use with cognitive decline in elderly African Americans
Szwast, S. J., Hendrie, H. C., Lane, K. A., Gao, S., Taylor, S., Unverzagt, F. W., Murrell, J. R., Deeg, M. A., Ogunniyi, A. O., Farlow, M. R., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000279333.77404.d7 · Cited by 74
Kostis, J. B., Rosen, R. C., & Wilson, A. C. (1994) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1994.tb01971.x · Cited by 73
Effects of Simvastatin on Cholesterol Metabolism and Alzheimer Disease Biomarkers
Serrano‐Pozo, A., Vega, G. L., Lütjohann, D., Locascio, J. J., Tennis, M. K., Deng, A., Atri, A., Hyman, B. T., Irizarry, M. C., & Growdon, J. H. (2010) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e3181d61fea · Cited by 70
Comparative effects of pravastatin and lovastatin on nighttime sleep and daytime performance
Richardson, G. S., Sullivan, J. P., Lee, R. M., Roth, T. G., Merlotti, L. A., & Roehrs, T. (1992) · Clinical Cardiology · doi:10.1002/clc.4960150607 · Cited by 70
Miida, T., Takahashi, A., & Ikeuchi, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.09.003 · Cited by 66
Blood Pressure and Cognition: Factors That May Account for Their Inconsistent Association
Power, M. C., Tchetgen Tchetgen, E. J., Sparrow, D., Schwartz, J., & Weisskopf, M. G. (2013) · Epidemiology · doi:10.1097/ede.0b013e3182a7121c · Cited by 63
Self-citationEffect of HMG-CoA Reductase Inhibitors on ??-Amyloid Peptide Levels
Höglund, K., & Blennow, K. (2007) · CNS Drugs · doi:10.2165/00023210-200721060-00002 · Cited by 63
Hypertension and Cognitive Function
Paglieri, C., BISBOCCI, D., Caserta, M., Rabbia, F., Bertello, C., Canadè, A., & Veglio, F. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802563584 · Cited by 62
Life long changes in cognitive ability are associated with prescribed medications in old age
Starr, J. M., McGurn, B., Whiteman, M. C., Pattie, A., Whalley, L. J., & Deary, I. J. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1093 · Cited by 60
Statins and Cognitive Decline in Older Adults with Normal Cognition or Mild Cognitive Impairment
Steenland, K., Zhao, L., Goldstein, F. C., & Levey, A. I. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12414 · Cited by 56
Effects of treatment with lovastatin and pravastatin on daytime cognitive performance
Gengo, F. M., Cwudzinski, D., Kinkel, P. R., Block, G. A., Stauffer, L. A., & Lines, C. (1995) · Clinical Cardiology · doi:10.1002/clc.4960180406 · Cited by 53
Statin use and incident dementia: A nationwide cohort study of Taiwan
Chou, C., Chou, Y., Chou, Y., Yang, Y.-F., & Huang, N. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.03.018 · Cited by 47
Cutler, N. R., Sramek, J. J., Veroff, A. E., Block, G. A., STAUFFER, L., & Lines, C. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb04458.x · Cited by 43
Butler, D. C., Kowall, N. W., Lawler, E. V., Gaziano, J. M., & Driver, J. A. (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03933.x · Cited by 42
Summers, M. J., Oliver, K. R., Coombes, J. S., & Fassett, R. G. (2007) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.2.183 · Cited by 38
Systematic review of statins for the prevention of vascular dementia or dementia
Muangpaisan, W., Brayne, C., & the Alzheimer's Society Vascular Dementia Systematic Review Group (2010) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2009.00579.x · Cited by 33
Statin treatment and a disease-specific pattern of β-amyloid peptides in Alzheimer’s disease
Höglund, K., Syversen, S., Lewczuk, P., Wallin, A., Wiltfang, J., & Blennow, K. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-2243-8 · Cited by 32
Carlsson, C. M., Xu, G., Wen, Z., Barnet, J. H., Blazel, H. M., Chappell, R. J., Stein, J. H., Asthana, S., Sager, M. A., Alsop, D. C., et al. (2012) · Current Alzheimer Research · doi:10.2174/156720512803251075 · Cited by 29
Effects of lovastatin and pravastatin on cognitive function in military aircrew.
Gibellato, M. G., Moore, J. L., Selby, K. A., & Bower, E. A. (2001) · PubMed · Cited by 28
Potential therapeutic role of statins in neurological disorders
Bifulco, M., Malfitano, A. M., & Marasco, G. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.5.827 · Cited by 23
Primary and secondary prevention of heart failure with statins
Udell, J. A., & Ray, J. G. (2006) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.4.6.917 · Cited by 13
Pollen, D. A., Baker, S. P., Hinerfeld, D. A., Swearer, J. M., Evans, B. A., Evans, J. E., Caselli, R. J., Rogaeva, E. A., George‐Hyslop, P. S., & Moonis, M. (2010) · Alzheimer s Research & Therapy · doi:10.1186/alzrt55 · Cited by 7
Twenty-six–Year Change in Total Cholesterol Levels and Incident Dementia
Stewart, R. J., White, L. R., Xue, Q., & Launer, L. J. (2007) · Archives of Neurology · doi:10.1001/archneur.64.1.103 · Cited by 3
Research works printed but not linked: 1
- Carlsson, C. M. et al. Effects of simvastatin on cerebrospinal fluid biomarkers and cognition in middle-aged adults at risk for Alzheimer's disease. J. Alzheimers Dis. 13, 187–197 (2008). · DOI
Cited by
Sorted by citations
Anderson, T. J., Grégoire, J., Pearson, G. J., Barry, A. R., Couture, P., Dawes, M., Francis, G. A., Genest, J., Grover, S., Gupta, M., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.07.510 · Cited by 1,173
Newman, C. B., Preiss, D., Tobert, J. A., Jacobson, T. A., Page, R. L., II, Goldstein, L. B., Chin, C. C., Tannock, L. R., Miller, M. J., Raghuveer, G., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000073 · Cited by 790
Anstey, K. J., Ashby-Mitchell, K., & Peters, R. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160826 · Cited by 360
Mancini, G. B. J., Baker, S. K., Bergeron, J., FITCHETT, D. H., Frohlich, J. J., Genest, J. J., Gupta, M., Hegele, R. A., Ng, D. S., Pearson, G. J., et al. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.01.003 · Cited by 257
Olmastroni, E., Molari, G., De Beni, N., Colpani, O., Galimberti, F., Gazzotti, M., Zambon, A., Catapano, A. L., & Casula, M. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwab208 · Cited by 197
Metadata
- Authors
- Power, M. C., Weuve, J., Sharrett, A. R., Blacker, D., & Gottesman, R. F.
- Affiliations
- Johns Hopkins University (US)
- Rush University Medical Center (US)
- Harvard University (US)
- Corresponding author
- Gottesman, Rebecca F.
- Venue
- Nature Reviews Neurology
- Published
- 2015-03-24
- Volume
- 11
- Issue
- 4
- Pages
- 220-229
- ISSN
- 1759-4758 (ISSN-L)
- 1759-4766
- PMC
- PMC4458855
- OpenAlex
- W2075092696
- Cited by
- 150
- References
- 100
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 15 · 2023: 20 · 2022: 11 · 2021: 9 · 2020: 15 · 2019: 14 · 2018: 15 · 2017: 19 · 2016: 7 · 2015: 5
- FWCI
- 2.11
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Alzheimer's Drug Discovery Foundation
- National Institute on Aging (P50AG005134, T32AG027668, P30AG062421)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- statins, cognitive decline, dementia, Alzheimer's disease, cognitive impairment, reverse causality, confounding, observational study design, randomized controlled trials
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cognition Disorders, Dementia, Female, Humans, Male, Middle Aged, Randomized Controlled Trials as Topic, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
